Inventor · disambiguated record
Marc Sadler Tesconi
Also filed as: TESCONI MARC · TESCONI MARC S · TESCONI MARC SADLER
6 granted patents·16 pending applications·24 citations·filing 2004–2014
79Inventor score
Top patents by PatentIndex Score
22 records- 0188US7759341B2Polymorph form II of tanaprogetWYETH LLC·Filed 2006·Granted Jul 20, 2010·11 cites·5 claims
- 0285US7968709B2Process for preparing polymorph form II of tanaprogetWYETH LLC·Filed 2010·Granted Jun 28, 2011·7 cites·6 claims
- 0377US7767678B2Crystalline forms of 4-[(2,4-dichloro-5-methoxyphenyl)amino]-6-methoxy-7-[3-(4-methyl-1-piperazinyl)propoxy]-3-quinolinecarbonitrile and methods of preparing the sameWYETH LLC·Filed 2006·Granted Aug 3, 2010·3 cites·21 claims
- 0476US8114869B2Polymorph form II of tanaprogetTESCONI MARC SADLER·Filed 2011·Granted Feb 14, 2012·3 cites·1 claims
- 0565US2009181979A1Pharmaceutically acceptable salts of quinolinone compounds having improved pharmaceutical propertiesNOVARTIS VACCINES & DIAGNOSTIC·Filed 2009·Application pending·0 cites
- 0660US2014303182A1Pharmaceutically acceptable salts of quinolinone compounds having improved pharmaceutical propertiesCAI SHAOPEI·Filed 2014·Application pending·0 cites
- 0759US2013338171A1Pharmaceutically Acceptable Salts of Quinolinone Compounds Having Improved Pharmaceutical PropertiesCAI SHAOPEI·Filed 2013·Application pending·0 cites
- 0858US2008188540A1Pharmaceutical compositions containing substituted indole acid derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1)WYETH CORP·Filed 2008·Application pending·0 cites
- 0958US2010113541A1Crystal forms of 2-(3-fluoro-4-hydroxyphenyl)-7-vinyl-1,3-benzoxazol-5-olWYETH LLC·Filed 2009·Application pending·0 cites
- 1057US2005209247A1Pharmaceutically acceptable salts of quinolinone compounds having improved pharmaceutical propertiesCHIRON CORP·Filed 2004·Application pending·0 cites
- 1157US2005137399A1Methods for synthesizing quinolinone compoundsCHIRON CORP·Filed 2004·Application pending·0 cites
- 1256US2012277434A1Methods for synthesizing quinolinone compoundsCAI SHAOPEI·Filed 2012·Application pending·0 cites
- 1355US7683182B2Crystal forms of 2-(3-fluoro-4-hydroxyphenyl)-7-vinyl-1,3-benzoxazol-5-olWYETH LLC·Filed 2006·Granted Mar 23, 2010·0 cites·13 claims
- 1455US2013018058A1Pharmaceutically acceptable salts of quinolinone compounds having improved pharmaceutical propertiesCAI SHAOPEI·Filed 2011·Application pending·0 cites
- 1552US2012115858A1Polymorph Form II of TanaprogetTESCONI MARC SADLER·Filed 2012·Application pending·0 cites
- 1650US2006121109A1Formulations of substituted benzoxazolesWYETH CORP·Filed 2005·Application pending·0 cites
- 1749US2006121111A1Formulations of substituted benzoxazolesWYETH CORP·Filed 2005·Application pending·0 cites
- 1847US2007249709A1Crystal forms of (S)-(8(2,6-dichlorophenyl)-6-fluoro-2,3-dihydro benzo[b][1,4]dioxin-2-yl)methanamine hydrochloride saltWYETH CORP·Filed 2007·Application pending·0 cites
- 1945US8445496B2Crystalline forms of 4-[(2,4-dichloro-5-methoxyphenyl)amino]-6-methoxy-7-[3-(4-methyl-1-piperazinyl)propoxy]-3-quinolinecarbonitrile and methods of preparing the sameTESCONI MARC SADLER·Filed 2010·Granted May 21, 2013·0 cites·13 claims
- 2043US2007191442A1Aqueous Pharmaceutical Formulations of ER-beta Selective LigandsTESCONI MARC S·Filed 2007·Application pending·0 cites
- 2143US2010056520A1Formulations of phospholipase enzyme inhibitorsDONAHUE FRANCES ANNE·Filed 2007·Application pending·0 cites
- 2240US2006121110A1Formulations of substituted benzoxazolesWYETH CORP·Filed 2005·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →